Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Daniel Och, Jim Chanos, Boaz Weinstein

Hedge Fund Och-Ziff Said to Lose Four London-Based Employees (Bloomberg)
Four employees of Daniel Och’s Och-Ziff Capital Management Group (OZM) have left the hedge fund’s London office over the past week, two people with knowledge of the matter said. Antonio Batista, Jason Marino, Marco Minoli and Filipe Bergana have departed the firm, one person said, asking not to be named as the details aren’t public. Batista was a managing director, while the other three were analysts, one person said.

Och-Ziff Capital Management

Hedge Fund Founder Chanos Says Shorting Intel Shares (Reuters)
Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp. “We’re short Intel,” Chanos told cable television network CNBC. Chanos said he has been shorting, or betting against the company’s shares, for the past six months. Chanos, who has been critical of the personal computer sector and has bet against companies such as International Business Machines Corp. and Hewlett-Packard Co., said Intel has “the same challenges.

Volatility No Help to Boaz Weinstein’s Struggles (WSJ)
The beleaguered hedge-fund manager Boaz Weinstein has repeatedly defended his unsuccessful trading of recent years by promising his positions will pay off when volatility returns to the market. Yet as The Wall Street Journal reported Friday, Mr. Weinstein’s losses at Saba Capital Management LP only accelerated amid the equity and oil market gyrations of the fourth quarter, according to investor documents and people familiar with the firm. In fact, most of the -11% annual loss occurred in the fourth quarter. What’s to blame? Even some of Mr. Weinstein’s own investors appear confused at the firm’s yearlong drought, with one telling MoneyBeat “I’ve never seen anything like this.”

Comac Capital’s Macro Fund Said to Drop 8 Percent on Swiss Franc (Bloomberg)
Comac Capital lost about 8 percent after the Swiss National Bank (SNBN)’s surprise decision to abandon the franc’s cap against the euro roiled markets worldwide, according to people with knowledge of the situation. Comac, a $1.2 billion London-based macro hedge fund run by Colm O’Shea, lost money on foreign-exchange trades as the franc surged as much as 41 percent versus the euro on Thursday, according to two people, who asked not to be identified because the matter is private.

Loeb King Says It’s Closing as Hedge Fund Rules ‘Cumbersome’ (Bloomberg)
Loeb King Capital Management, an investment firm with about $1 billion, is closing after principal Gideon King decided to manage his own money. “You will just be more profitable if you run your own capital,” King, 45, said in a telephone interview. “That’s 99.9 percent of the decision.” King informed clients in a Jan. 13 letter that the funds will begin an orderly liquidation. The decision isn’t related to the business prospects, he wrote, but because the industry has changed and there are better ways to deploy capital.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.